Elevance Health, Inc. 4

Gail Boudreaux, President and CEO of Elevance Health, purchased 2,725 shares of Elevance Health common stock on July 17, 2026 for about $1.0 million in total.

On July 17, 2026, Elevance Health President and CEO Gail Boudreaux reported two open‑market purchases of Elevance Health, Inc. common stock, acquiring 680 shares at a weighted average price of $366.41 and an additional 2,045 shares at a weighted average price of $368.25. These trades, executed in multiple transactions within disclosed price ranges, totaled 2,725 shares and approximately $1.0 million in aggregate consideration. Following these purchases, Boudreaux’s directly held ownership increased to 171,976 shares, while a separate 60 shares are reported as indirectly owned in her spouse’s revocable trust, bringing her total reported beneficial ownership to 172,036 shares, representing a meaningful direct equity commitment by the CEO at prices near the prevailing market level.

Filing Facts

CIK

1156039

Ticker

ELV

Form

4

Source Type

sec

Accession

0001287920-26-000006

Alert Tier

8